We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.49B
AUM Growth
-$90.6M
Cap. Flow
-$54.8M
Cap. Flow %
-3.67%
Top 10 Hldgs %
29.45%
Holding
140
New
5
Increased
31
Reduced
71
Closed
10

Top Buys

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$18.6M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$15.9M
3
CMD
Cantel Medical Corporation
CMD
+$15.1M
4
MLAB icon
Mesa Laboratories
MLAB
+$4.76M
5
DORM icon
Dorman Products
DORM
+$2.99M

Top Sells

Rank Stock Value
1
HITT
HITTITE MICROWAVE CORP
HITT
+$26.4M
2
ABAX
Abaxis Inc
ABAX
+$14.2M
3
FARO
Faro Technologies
FARO
+$13.7M
4
BCPC
Balchem Corp
BCPC
+$7.13M
5
ALGN icon
Align Technology
ALGN
+$4.3M

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Healthcare 20.07%
3 Industrials 15.68%
4 Materials 8.38%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOPE icon
26
Grand Canyon Education
LOPE
$3.79B
$30.6M 2.05%
665,201
-44,424
-6% -$2M
FLTX
27
DELISTED
Fleetmatics Group PLC
FLTX
$30.5M 2.05%
943,181
+46,631
+5% +$1.43M
MCF
28
DELISTED
Contango Oil & Gas Co.
MCF
$29M 1.94%
684,922
+20,192
+3% +$899K
ABAX
29
DELISTED
Abaxis Inc
ABAX
$28.4M 1.91%
641,146
-342,414
-35% -$14.2M
SSYS icon
30
Stratasys
SSYS
$679M
$27.2M 1.83%
239,796
-10,215
-4% -$1M
HIBB
31
DELISTED
Hibbett, Inc. Common Stock
HIBB
$26.9M 1.81%
497,170
-32,026
-6% -$1.73M
EGOV
32
DELISTED
NIC Inc
EGOV
$26.6M 1.79%
1,680,458
-10,945
-0.6% -$191K
MLAB icon
33
Mesa Laboratories
MLAB
$564M
$26.2M 1.76%
311,881
+57,570
+23% +$4.76M
FARO
34
DELISTED
Faro Technologies
FARO
$25.7M 1.72%
522,438
-299,423
-36% -$13.7M
SQI
35
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
$25M 1.68%
1,412,432
-32,564
-2% -$650K
ABCO
36
DELISTED
Advisory Board Co
ABCO
$24M 1.61%
463,795
-46,715
-9% -$2.53M
RGEN icon
37
Repligen
RGEN
$7.96B
$23.8M 1.6%
+1,044,319
New +$18.6M
ROL icon
38
Rollins
ROL
$18.3B
$22.7M 1.53%
2,559,249
-420,164
-14% -$3.77M
MDSO
39
DELISTED
Medidata Solutions, Inc.
MDSO
$21.1M 1.41%
492,550
+15,533
+3% +$645K
TECH icon
40
Bio-Techne
TECH
$11.2B
$15.9M 1.07%
688,228
-11,688
-2% -$258K
NVEC icon
41
NVE Corp
NVEC
$562M
$15.5M 1.04%
278,373
+7,741
+3% +$414K
MED icon
42
Medifast
MED
$109M
$15.4M 1.03%
506,793
+28,730
+6% +$895K
VIVO
43
DELISTED
Meridian Bioscience Inc
VIVO
$15.2M 1.02%
737,319
+6,722
+0.9% +$138K
LGND icon
44
Ligand Pharmaceuticals
LGND
$5.76B
$15.2M 1.02%
+391,079
New +$15.9M
NRCIB
45
DELISTED
National Research Corp Class B
NRCIB
$14.7M 0.99%
376,236
+48,058
+15% +$1.99M
MORN icon
46
Morningstar
MORN
$7.22B
$13.9M 0.93%
194,012
-38,704
-17% -$2.83M
ACTG icon
47
Acacia Research
ACTG
$428M
$13.6M 0.91%
767,401
+11,669
+2% +$189K
NRC icon
48
NRC Health Common Stock
NRC
$432M
$13.3M 0.9%
954,225
-17,193
-2% -$259K
EXA
49
DELISTED
EXA Corporation
EXA
$7.09M 0.48%
630,077
+44,577
+8% +$463K
UFI icon
50
UNIFI
UFI
$119M
$4.18M 0.28%
151,804
+1,025
+0.7% +$24.1K
1
2
3 4 5

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return

Conestoga Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Conestoga Capital Advisors held 140 positions worth $1.49B, down 5.7% from $1.58B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors withdrew a net $54.8M in Q2 2014, closing 10 positions and reducing 71 holdings. Its most notable exit was HITTITE MICROWAVE CORP, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in Repligen worth $23.8M.

  • Conestoga Capital Advisors's largest Q2 2014 buy was Repligen: 1,044,319 shares worth $23.8M.
  • Conestoga Capital Advisors added most to Cantel Medical Corporation in Q2 2014, an estimated $15.1M increase.
  • Conestoga Capital Advisors's biggest Q2 2014 reduction was Abaxis Inc, cutting an estimated $14.2M.
  • Conestoga Capital Advisors fully exited HITTITE MICROWAVE CORP in Q2 2014, selling an estimated $26.4M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.49B portfolio in Q2 2014.
  • Conestoga Capital Advisors opened 5 new positions and closed 10 in Q2 2014.
  • Conestoga Capital Advisors's portfolio value fell 5.7% quarter-over-quarter to $1.49B.

Based on Conestoga Capital Advisors's 13F filing for Q2 2014, filed 8 Jul 2014.